TP53 and infection: 1. Hematologic: Peripheral blood ctDNA (monthly, monitor for clonal expansion)2. Safety: Infection surveillance (weekly, neutropenic fever protocol)3. Pharmacodynamics: p53 protein expression (IHC, end of cycle 1; target: nuclear p53 positivity in ≥20% of blasts)